# Levothyroxine Sodium

NDC: 0378-1807
Generic name: levothyroxine sodium
Labeler / Manufacturer: Mylan Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20021101

FDA application: ANDA076187

## Active ingredients

- LEVOTHYROXINE SODIUM: 88 ug/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0378-1807"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0378-1807
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e95720f2-91c9-a6d0-f7d5-8bcb94d07bbc